Feng Luo

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors

Josep Tabernero, Rastislav Bahleda, Rodrigo Dienstmann et al. · Journal of Clinical Oncology · 2015 · 384 citations

Medicine, Pharmacokinetics, Pharmacology +14

Targeting Prodromal Alzheimer Disease With Avagacestat

Vladimir Coric, Stephen Salloway, Christopher H. van Dyck et al. · JAMA Neurology · 2015 · 233 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression

Hanbing Lu, Sachin Patel, Feng Luo et al. · Magnetic Resonance in Medicine · 2004 · 135 citations

Life Sciences, Neurobiology, Neuroscience +15

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies

Diana W. Shineman, Guriqbal S. Basi, Jennifer L. Bizon et al. · Alzheimer s Research & Therapy · 2011 · 135 citations · Full text

Medicine, Pharmacology, Dementia +16

Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumors

Faye M. Johnson, Shruti Agrawal, Howard A. Burris et al. · Cancer · 2010 · 124 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11